r/AIdaily_news

Kaufmyn was part of StopAI, a group protesting OpenAI’s pursuit of artificial superintelligence. During the February 2025 demonstration, activists chained and locked the company’s front doors, while Kaufmyn remained in a sit-in after being ordered to leave.

A jury convicted her in June on misdemeanor charges including interfering with a business, trespassing with intent to interfere with a business, unlawful assembly and refusal to disperse at a riot.

Kaufmyn argued that her actions were necessary because she believed advanced AI could pose an existential threat. The jury rejected that defense, and San Francisco District Attorney Brooke Jenkins said the verdict sent a message that protesters cannot endanger public safety as a means to an end.

The case comes as concerns about AI safety are becoming more prominent. More than 1,000 researchers at frontier AI labs signed a letter this summer warning of a “real risk” that AI development could accelerate beyond humanity’s ability to understand or control the resulting systems.

AI safety professor Stuart Russell also testified in Kaufmyn’s defense, arguing that further development should require rigorous safety guarantees.

For the AI industry, the case highlights a growing tension between rapid technological progress, public concern and demands for stronger safety measures.

Amodei wrote on X that saying AI will cure cancer has become “more a cliché than it is inspiring,” because many people now view such claims as deceptive. His argument is that the industry needs to demonstrate real-world results rather than make bigger promises.

The comments come as AI companies face growing criticism over massive data-center expansion, the use of copyrighted online data for training, and disruption across the workforce.

Amodei also rejected the idea that his own warnings about AI risks are responsible for public distrust. He argued that skepticism toward AI companies is part of a broader distrust of corporations that has developed over decades.

Not everyone agrees that scientific breakthroughs alone will be enough. Angel Brodin, an applied AI architect at OpenAI, argued that people will also judge AI companies based on pricing, access, lobbying, transparency, and how the economic benefits of AI are distributed.

Anthropic is increasing its work in biology and medicine, with Amodei saying the company hopes to see “early glimmers” in the coming months and significant results in the coming years.

For the AI industry, the challenge is becoming clearer: public trust may depend less on predictions about what AI could accomplish and more on measurable results that people can actually see.

Via WSJ

Apple is reportedly testing chips from CXMT and YMTC for devices sold in China. Commerce Secretary Howard Lutnick says he told Apple “plainly” that Washington opposes the move.

Apple can legally buy standard, off-the-shelf parts from both companies. Sharing product information for customized chips would require a U.S. license.

Looks like ram shortage will continue and prices stay high.